Associations of severe COVID-19 with polypharmacy in the REACT-SCOT case-control study

Paul M McKeigue; Sharon Kennedy; Amanda Weir; Jen Bishop; Stuart J McGurnaghan; David McAllister; Chris Robertson; Rachael Wood; Nazir Lone; Janet Murray; Thomas M Caparrotta; Alison Smith-Palmer; David Goldberg; Jim McMenamin; Colin Ramsay; Bruce Guthrie; Sharon Hutchinson; Helen M Colhoun.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-20160747

Documentos relacionados

  1. Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study.
  2. [Erythropoesis-stimulating agents: past, present and future].
  3. Gadolinium-based contrast agents: What we learned from acute adverse events, nephrogenic systemic fibrosis and brain retention.